A clinical study of Evenamide (NW-3509) in patients with schizophrenia experiencing worsening of psychosis on atypical antipsychotics
Phase of Trial: Phase III
Latest Information Update: 11 Dec 2017
At a glance
- Drugs Evenamide (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- 11 Dec 2017 According to a Newron Pharmaceuticals media release, this study expected to start in early 2018.
- 27 Sep 2017 New trial record
- 26 Sep 2017 According to a Newron Pharmaceuticals media release, the company is completing the design of this trial.